Prospects for the Use of Antioxidant Therapies

Drugs

Volumn 49, Issue 3, 1995, Pages 345-361

  Maxwell, Simon R J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BILIRUBIN; CATALASE; CERULOPLASMIN; ESTROGEN; FLAVONOID; FREE RADICAL; GLUTATHIONE PEROXIDASE; SCAVENGER; SUPEROXIDE DISMUTASE; TOCOPHEROL; TRANSFERRIN; URIC ACID; VITAMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CANCER; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; ENTERITIS; FEMALE; HUMAN; HYPERTENSION; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MUSCLE ISCHEMIA; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PROPHYLAXIS; REVIEW;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIOXIDANTS; ARTERIOSCLEROSIS; CENTRAL NERVOUS SYSTEM DISEASES; DIABETES MELLITUS; ENZYMES; EXERCISE; FREE RADICAL SCAVENGERS; FREE RADICALS; GRAFT REJECTION; HUMAN; HYPERTENSION; INFLAMMATION; NEOPLASMS; REPERFUSION INJURY;

EID: 0028931178     PISSN: 00126667     EISSN: 11791950     Source Type: Journal    
DOI: 10.2165/00003495-199549030-00003     Document Type: Review

References (140)

1. Oxidants and antioxidants: state of the art
2. Tissue destruction by neutrophils
3. Role of metals in oxygen radical reactions
4. Mechanisms and consequences of lipid peroxidation in biological systems
5. Iron ion-dependent modification of bases in DNA by the superoxide radical generating system hypoxanthine/xanthine oxidase
6. The production of DNA strand breaks in human leukocytes by superoxide may involve a metabolic process
7. Radiation effects on DNA
8. Superoxide dismutase and catalase as therapeutic agents for human diseases: a critical review
9. Glutathione peroxidase protein: absence in selenium-deficiency states and correlation with enzymatic activity
10. The pharmacology of ebselen
11. Endogenous antioxidant defences in human blood plasma
12. Survival and desferrioxamine in thalassaemia major
13. How to characterize a biological antioxidant
14. Direct observation of a free radical interaction between vitamin E and vitamin C
15. Probucol: pharmacology and clinical application
16. Generation and recycling of radicals from phenolic antioxidants
17. Synergistic interaction between the probucol phenoxyl radical and ascorbic acid in inhibiting the oxidation of low density lipoprotein
18. The scavenging of oxidants by sulphasalazine and its metabolites
19. Central nervous system trauma and stroke
20. A trial of the 21-aminosteroid U74006F in a primate model of chronic cerebral vasospasm
21. Oxygen-derived free radicals in post-ischaemic tissue injury
22. Action of uric acid, allopurinol, and oxypurinol on the myeloperoxidase-de-rived oxidant hypochlorous acid
23. Xanthine oxidoreductase activity in perfused hearts of various species, including humans
24. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity
25. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
26. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
27. Autoantibody against oxidized LDL and progression of carotid atherosclerosis
28. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene
29. Susceptibility to low density lipoprotein oxidation and coronary atherosclerosis in man
30. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit
31. Inverse correlation between plasma vitamin E and mortality from ischaemic heart disease in cross-cultural epidemiology
32. Risk of angina pectoris and plasma concentrations of vitamins A, C, E and carotene
33. A prospective study of the intake of antioxidant vitamins and incidence of coronary heart disease in women [abstract]
34. The Scottish Heart Health Study: dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk
35. Antioxidants in adipose tissue and risk of myocardial infarction: the Euramic study
36. Vitamin E consumption and the risk of coronary heart disease in men
37. Vitamin E consumption and the risk of coronary heart disease in women
38. Antioxidants and atherosclerosis progression
39. Dietary antioxidant flavanoids and risk of coronary heart disease: the Zutphen Elderly Study
40. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
41. Red wine and serum antioxidant activity
42. Low-dose alpha-tocopherol improves and high-dose alpha-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits
43. A randomised comparison of streptokinase vs plasminogen activator vs antistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction
44. Oxygen free radicals and cardiac reperfusion abnormalities
45. The stunned myocardium — prolonged post-ischemic ventricular dysfunction
46. Reperfusion-induced arrhythmias and oxygen-derived free radicals
47. Free radicals, antioxidants and endothelial cell damage after percutaneous transluminal coronary angioplasty
48. Lipid peroxidation associated with successful thrombolysis
49. Detection of free radicals and cholesterol hydroperoxides from the coronary sinus of man during percutaneous transluminal coronary angioplasty
50. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues
51. Reperfusion injury and its pharmacological modification
52. Use of spin traps in intact animals undergoing myocardial ischaemia/reperfusion: a new approach to assessing the role of oxygen radicals in myocardial stunning
53. Pathogenesis and treatment perspectives of chronic graft rejection (CVR)
54. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants
55. Does antioxidant treatment have a role in liver transplantation?
56. Evidence that Carolina rinse solution protects sinusoidal endothelial cells against reperfusion injury after cold ischaemic storage of rat liver
57. Delayed cardiac allograft rejection due to combined cyclosporine and antioxidant therapy
58. Reperfusion injury, antioxidants and haemodynamics during orthotopic liver transplantation
59. Pathogenesis of diabetic microangiopathy: an overview
60. Atherogenesis in diabetes
61. Increased diene conjugates in patients with diabetic microangiopathy
62. The fluorescence of serum proteins in patients with and without retinopathy
63. Hydroxyl radical production and autooxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
64. Oxidative glycation and free radical production: a causal mechanism of diabetic complications
65. Advanced glycosylation end-products in tissue and the biochemical basis of diabetic complications
66. Role of advanced glycosylation products in complications of diabetes
67. Serum antioxidant activity in diabetes mellitus
68. Disturbed handling of ascorbic acid in diabetic patients with and without diabetic microangiopathy using high dose ascorbate supplementation
69. Lipid peroxides and atherosclerosis
70. Effects of ascorbic acid on non-enzymatic glycation of serum proteins in vitro and in vivo [abstract]
71. A preliminary note on inhibiting effect of alpha-tocopherol (vitamin E) on protein glycation
72. Vitamin E reduction of protein glycosylation in diabetes: new prospects for prevention of diabetic complications?
73. New insights on non-enzymatic glycosylation may lead to therapeutic approaches for the prevention of diabetic complications
74. Oxygen-dependent microbial killing by phagocytes
75. Oxidants, inflammation and anti-inflammatory drugs
76. Tissue injury in inflammation: oxidants, proteinases, and cationic proteins
77. Iron mobilisation from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: possible mechanism in inflammation diseases
78. Free radicals in inflammation: secondary messengers and mediators of tissue distinction
79. Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation
80. The role of oxygen radicals in experimental acute pancreatitis
81. Antioxidant therapy for recurrent pancreatitis: placebo-controlled trial
82. Can dietary beta-carotene materially reduce human cancer rates?
83. Dietary carotenes, vitamin C, and vitamin E as protective antioxidants in human cancers
84. Biological actions of carotenoids
85. Beta-carotene and cancer prevention: the Basel Study
86. Micronutrients and cancer chemoprevention
87. Micronutrients and cancer prevention
88. DNA damage by smoke: protection by tumeric and other inhibitors of ROS
89. Failure of high dose vitamin E to correct caeruloplasmin ferroxidase deficiency in cigarette smokers
90. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
91. Vitamin C and blood pressure
92. Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects
93. Does superoxide underlie the pathogenesis of hypertension?
94. Superoxide ion is involved in the breakdown of endothelium-derived relaxing factor
95. Superoxide anions and hyperoxide inactivate endothelium-derived relaxing factor
96. Involvement of oxygen radicals in shock and organ failure
97. Use of antioxidant therapy in shock and trauma
98. Free radicals and antioxidants in sepsis
99. Scientific perspectives on adult respiratory distress syndrome
100. Oxygen radicals and the nervous system
101. Antioxidant effects in brain and spinal cord injury
102. Initiating the treatment of Parkinson’s disease
103. A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson’s disease
104. Systemic glutathione deficiency in symptom-free HIV-seropositive patients
105. Reactive oxygen species, antioxidants and the acquired immunodeficiency syndrome
106. Cytokine stimulated human immunodeficiensy virus replication is inhibited by N-acetyl-L-cysteine
107. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly subjects
108. Exercise, oxidative damage and effects of antioxidant manipulation
109. Free radical and tissue damage produced by exercise
110. Antioxidant status and indexes of oxidative stress during consecutive days of exercise
111. Increased blood antioxidant systems of runners in response to training load
112. Changes in plasma antioxidant status during eccentric exercise and the effect of vitamin supplementation
113. Effect of antioxidant vitamin supplementation on muscle function after eccentric exercise
114. Free radicals and trials of antioxidant therapy in muscle disorders
115. The neurologic syndrome of vitamin E deficiency: laboratory and electrophysiological assessment
116. Vitamin E supplementation and periventricular haemorrhage in the newborn
117. Induction of lipid peroxidation of pulmonary surfactant by plasma of preterm babies
118. Scientific basis for the medical therapy of cataracts by antioxidants
119. Nutrient intake and cataract extraction in women: a prospective study
120. Is there a prevention and treatment trategy for macular degeneration?
121. Photoprotection by carotenoids
122. Dermatologic antioxidant therapy may be warranted to prevent ultraviolet-induced skin damage
123. Use of N-acetylcysteine in clinical toxicology
124. Free radical mediated cell toxicity by redox cycling chemicals
125. Erythrocyte antioxidant activity, serum caeruloplasmin, and trace element levels in subjects with alcoholic liver disease
126. The effect of antioxidant supplementation on a serum marker of free radical activity and abnormal serum biochemistry in alcoholic patients admitted for detoxification
127. Antioxidant therapy in congestive heart failure: is there any advantage?
128. Perspectives on therapy of cardiovascular diseases with co-enzyme Q10 (ubiquinone)
129. Free radical activity in chronic heart failure and the effect of Captopril
130. Trace element and lipid peroxidation abnormalities in patients with chronic renal failure
131. Membrane phospholipid peroxidation in renal insufficiency and chronic haemodialysis
132. Sera antioxidant activity in uncomplicated and pre-eclamptic pregnancies
133. Enhanced superoxide production with no change of the antioxidant activity in gingival fluid of patients with chronic adult periodontitis
134. Oxidants and respiratory tract epithelial injury: pathogenesis and strategies for therapeutic intervention
135. Antioxidant therapy in haematological disorders
136. Current status of antioxidant therapy
137. Prospects for treatment of free radical-mediated tissue injury
138. Mechanisms of cardiovascular drugs as antioxidants
139. Prospects for antioxidant therapy in cardiovascular medicine